Decreased survival after conversion to serum HER-2/neu positive.

被引：0
|
作者：
Lipton, A
Leitzel, K
Ali, SM
Demers, L
Harvey, HA
Chaudri-Ross, H
Lang, R
Hackl, W
Hamer, P
Carney, W
机构：
[1] W Penn State Hershey Med Ctr, Hershey, PA USA
[2] Lebanon VA Med Ctr, Lebanon, PA USA
[3] Novartis Pharma AG, Basel, Switzerland
[4] Oncogene Sci Bayer Diagnost, Cambridge, MA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
508
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [41] Tissue expression and serum levels of HER-2/neu in patients with breast cancer
    Krainer, M
    Brodowicz, T
    Zeillinger, R
    Wiltschke, C
    Scholten, C
    Seifert, M
    Kubista, E
    Zielinski, CC
    ONCOLOGY, 1997, 54 (06) : 475 - 481
  • [42] Expression of the HER-2/neu oncoprotein in serum in patients with renal cell carcinoma
    Rasmuson, T
    Grankvist, K
    Ljungberg, B
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 454 - 454
  • [43] Pathological Response and Survival after Neoadjuvant Therapy for Her-2 Positive Breast Cancer
    Jinga, Dan Corneliu
    Jinga, Maria Ruxandra
    Miron, Adrian
    Noditi, Aniela
    Blidaru, Alexandru
    CHIRURGIA, 2021, 116 (02) : S91 - S97
  • [44] Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen
    Lipton, A
    Ali, SM
    Leitzel, K
    Demers, L
    Harvey, HA
    Chaudri-Ross, HA
    Brady, C
    Wyld, P
    Carney, W
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) : 1967 - 1972
  • [45] Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification
    Lal, P
    Salazar, PA
    Ladanyi, M
    Chen, BY
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2003, 5 (03): : 155 - 159
  • [46] Tissue expression and serum levels of HER-2/neu in patients with breast cancer
    Brodowicz, T
    Krainer, M
    Zeillinger, R
    Budinsky, AC
    Wiltschke, C
    Zielinski, CC
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 657 - 657
  • [47] Clinical use of the serum marker HER-2/NEU in patients with breast cancer
    Dalu, D.
    Cattaneo, M. T.
    Piazza, E.
    Piva, S.
    Gambaro, A.
    Tosca, N.
    Gabris, A.
    Filipazzi, V
    Esani, G.
    Somma, L.
    Sarnataro, C.
    Zambelli, S.
    Damiani, E.
    ANNALS OF ONCOLOGY, 2007, 18 : 45 - 45
  • [48] HER-2/neu in tissue and serum at time of primary diagnosis of breast cancer
    Dresse, M.
    Mayr, D.
    Heinemann, V.
    Kahlert, S.
    Bauerfeind, I.
    Nagel, D.
    Seidel, D.
    Stieber, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] HER-2/NEU IN TISSUE AND SERUM AT TIME OF PRIMARY DIAGNOSIS OF BREAST CANCER
    Dresse, M.
    Mayr, D.
    Heinemann, V.
    Kahlert, S.
    Bauerfeind, I.
    Nagel, D.
    Seidel, D.
    Stieber, P.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4027 - 4027
  • [50] Serum HER-2/neu levels in men with suspected prostate cancer.
    Croal, BL
    Mitchell, ID
    Mutch, MJ
    Kulkarni, UV
    Dickie, A
    Cohen, NP
    Ross, IS
    CLINICAL CHEMISTRY, 2001, 47 (06) : A136 - A136
12345